Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination

Journal of Clinical Oncology

Volumn 13, Issue 11, 1995, Pages 2769-2775

  Krismann, Michael ^b   Todt, Birgit ^b   Schröder, Jan ^b   Gareis, Dorothee ^b   Müller, Klaus Michael ^b   Seeber, Siegfried ^b   Schütte, Jochen ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; CYTOKERATIN 19;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TISSUE SPECIFICITY;

EID: 0028883684     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1995.13.11.2769     Document Type: Article

References (36)

1. Ginsberg RJ, Kris MG, Armstrong JG: Cancer of the lung, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 4). Philadelphia, PA, Lippincott, 1993, pp 673-723
2. Roth MS, Antin JH, Bingham EL, et al: Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood 74:882-885, 1989
3. Mattano LA, Moss TJ, Enerson SG: Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 52:4701-4705, 1992
4. Naito H, Kuzumaki N, Uchino J, et al: Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer 27:762-765, 1991
5. Smith B, Selby P, Southgate J, et al: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338:1227-1229, 1991
6. Datta YH, Adams PT, Drobyski WR, et al: Sensitive detection of occult breast cancer by reverse-transcriptase polymerase chain reaction. J Clin Oncol 12:475-482, 1994
7. Krüger H, Stockschläder M, Zander AR: Detection of epithelial specific RNA in blood and bone marrow with a RT-based polymerase chain reaction. Proc Am Soc Clin Oncol 13:68, 1994 (abstr 74)
8. Fields K, Moscinski L, Trudeau W, et al: The use of polymerase chain reaction for amplification of cytokeratin 19 to detect bone marrow micrometastases in breast cancer. Proc Am Soc Clin Oncol 13:115, 1994 (abstr 262)
9. Wood DP, Banks ER, Humphries S, et al: Comparison of immunohistochemistry and polymerase chain reaction amplification of mRNA in the detection of prostate cancer micrometastases. Proc Am Assoc Cancer Res 34:190, 1993 (abstr 1135)
10. Schlimok G, Funke I, Bock B, et al: Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 8:831-837, 1990
11. Souhami RL, Beverley PCL, Bobrow LG: Proceedings of the first international workshop on small cell lung cancer. Lancet 2:325-326, 1987
12. Stahel RA, Mabry M, Skarin AT, et al: Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol 3:455-461, 1985
13. Hansen HH, Muggia FM, Selawry OS: Bone marrow examination in 100 consecutive patients with bronchogenic carcinoma. Lancet 2:443-445, 1971
14. Hirsch F, Hansen HH, Dombernowsky P, Hainau B: Bone marrow examination in the staging of small-cell anaplastic carcinoma of the lung with special reference to subtyping. Cancer 39:2563-2567, 1977
15. Postmus PE, Hirschler-Schulte TJW, de Leij L, et al: Diagnostic application of a monoclonal antibody against small cell lung cancer. Cancer 57:60-63, 1986
16. Cote RJ, Rosen PP, Lesser ML, et al: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9:1749-1756, 1991
17. Leonard RCF, Duncan LW, Hay FG: Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancer. Cancer Res 50:6545-6548, 1990
18. Leslie DS, Johnston WW, Daly L, et al: Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytology. Am J Clin Pathol 94:8-13, 1990
19. Beiske K, Myklebust AT, Aamdal S, et al: Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods. Am J Pathol 141:531-538, 1992
20. Osborne MP, Asina S, Wong GY, et al: Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: Sensitivity in a model system. Cancer Res 49:2510-2513, 1989
21. Traweek ST, Liu J, Battifora H: Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol 142:1111-1118, 1993
22. Franke WW, Schiller D, Moll R, et al: Diversity of cytokeratins: differentiation-specific expression of cytokeratin polypeptides in epithelial cells and tissues. J Mol Biol 153:933-959, 1981
23. Leube RE, Bosch FX, Romano V, et al: Cytokeratin expression in simple epithelia. III. Detection of mRNAs encoding human cytokeratins nos. 8 and 18 in normal and tumor cells by hybridization with cDNA sequences in vitro and in situ. Differentiation 33:69-85, 1986
24. Makin CA, Bobrow LG, Bodmer WF: Monoclonal antibodies to cytokeratin for use in routine histopathology. J Clin Pathol 37:975-983, 1984
25. Moll R, Franke WW, Schiller DL, et al: The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24, 1982
26. Moll R, Krepler R, Franke WW: Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation 23:256-269, 1983
27. Broers JLV, Ramaekers FCS, Rot MK, et al: Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res 48:3221-3229, 1988
28. Bartek J, Bartkova J, Schneider J, et al: Expression of monoclonal antibody-defined epitopes of keratin 19 in human tumours and cultured cells. Eur J Cancer Clin Oncol 22:1441-1452, 1986
29. Pujol JL, Grenier J, Daures JP, et al: Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 53:61-66, 1993
30. Chomczynsky P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
31. Arcari P, Martinelli R, Salvatore F: A complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: Evidence for multiple mRNA species. Nucleic Acids Res 12:9179-9185, 1984
32. Bader BL, Jahn L, Franke WW: Low level expression of cytokeratins 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeratin 19 gene. Eur J Cell Biol 47:300-319, 1988
33. Savatchenko ES, Schiff TA, Jiang CK, et al: Embryonic expression of the human 40-kD keratin: Evidence from a processed pseudogene sequence. Am J Hum Genet 43:630-637, 1988
34. Chelly J, Concordet JP, Kaplan JC, et al: Illegitimate transcription: Transcription of any gene in any cell type. Proc Natl Acad Sci USA 86:2617-2621, 1989
35. Sarkar G, Sommer SS: Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. Science 244:331-334, 1989
36. Wulf GG, Schweiger C, Hannemann P, et al: RT/PCR of parathormone related protein (PTHrP) and cytokeratins 8, 18 and 19 for the detection of micrometastases in patients with lung cancer. Proc Am Soc Clin Oncol 13:341, 1994 (abstr 1134)